Skip to main content
. 2023 Jul 17;24(10):539–549. doi: 10.2217/pgs-2023-0039

Figure 2. . Comfort ordering a pharmacogenomic test, by specialty and timepoint.

Figure 2. 

Providers responded to the statement, “I feel comfortable ordering a pharmacogenetic test to predict risk of adverse events or likelihood of response (e.g., CYP2C9/VKORC1 and warfarin therapy)”. Percentages responding ‘agree’ or ‘strongly agree’ were adjusted for respondents' role, age and gender.

OB/GYN: Obstetrics/gynecology; PGx: Pharmacogenomic.